Diabetes

New Research Reveals Link Between High Blood Sugar and Upper Limb Problems

(IN BRIEF) A recent study led by the University of Exeter has identified a connection between consistently high blood sugar…

3 months ago

IQ Biozoom Innovates Non-Invasive Self-Testing, Empowering People to Self-Monitor with Laboratory Precision at Home

(IN BRIEF) IQ Biozoom, a medical technology startup, is developing non-invasive home diagnostics that allow people to measure the concentration…

6 months ago

Novo Nordisk’s Bid for BIOCORP Set at 35.00 Euros per Share, Totaling 154 Million Euros

(IN BRIEF) Novo Nordisk A/S is in exclusive negotiations to acquire a controlling stake in BIOCORP Production SA, a French…

11 months ago

Novo Nordisk and Aspect Biosystems collaborate to create disease-modifying treatments for diabetes and obesity

(IN BRIEF) Novo Nordisk has announced a collaboration with Aspect Biosystems to develop bioprinted tissue therapeutics for diabetes and obesity…

1 year ago

12-month real-world achievements for Diabeloop’s Automated Insulin Delivery (AID):

4 million1 hours of hypoglycemia avoided Trust in the algorithm leads to fewer meal declarations Users report a significantly reduced…

2 years ago

Diabeloop adapts its self-learning, personalized insulin automatization software to be used with insulin pens

(PRESS RELEASE) PARIS, 12-Apr-2022 — /EuropaWire/ — Diabeloop, a pioneer in the field of therapeutic artificial intelligence, leverages the potential…

2 years ago

University of Exeter led research may be at the doorstep of finding a treatment for the common diabetes complication hypoglycaemia

(PRESS RELEASE) EXETER, 17-Dec-2021 — /EuropaWire/ — University of Exeter, a public research university in Exeter, Devon, South West England,…

2 years ago

Significant improvement in increasing Time In Range and reducing hypoglycemia among people equipped with Diabeloop DBLG1

EASD 2021 - Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, is presenting new real-world data(1) of its…

3 years ago

De zelflerende algoritme DBLG1®: eenvoudig te gebruiken voor een optimale en gepersonaliseerde behandeling van diabetes type 1

(PRESS RELEASE) PARIJS, 2-Jun-2021 — /EuropaWire/ — Vanaf het begin heeft Diabeloop innovatieve systemen ontwikkeld om de behandeling van diabetes…

3 years ago

Sanofi launches more impactful Corporate Social Responsibility (CSR) strategy

Accelerating projects on access to medicines, support for vulnerable communities, environmental conservation, and diversity and inclusion Creation of Sanofi Global Health, global…

3 years ago

Technical University of Munich scientists described a new class of designed macrocyclic peptides that are highly potent inhibitors of amyloid formation

MUNICH, 14-Aug-2018 — /EuropaWire/ — Effective therapeutics to counteract the formation of amyloid plaques in Alzheimer's disease and type 2 diabetes…

6 years ago

KTH researchers produced microparticles with encapsulated cells that can be used as implants to fight cancer, diabetes or heart disease

STOCKHOLM, 18-Apr-2018 — /EuropaWire/ — One way that cancer may be fought in the future is with micro-sized capsules containing living…

6 years ago

Dr Will Johnson of Loughborough University: the concept of ‘healthy obesity’ is inherently flawed

Leicestershire, UK, 17-Apr-2018 — /EuropaWire/ — The on-going debate over whether ‘health obesity’ exists is diverting attention away from effective medical…

6 years ago

Diabetes: US FDA approval for Medtronic’s Guardian(TM) Connect continuous glucose monitoring (CGM) system

 'Smart' CGM System Provides Predictive Alerts for Dangerous Sensor Glucose Levels; Exclusive Access to Sugar.IQ Assistant with Watson Offers More Proactive Diabetes…

6 years ago

Medtronic at the Advanced Technologies & Treatments for Diabetes (ATTD) 11th International Conference in Vienna, Austria, February 14-17

Medtronic Will Host an Exclusive Symposium on Thursday, February 15 VIENNA, 14-Feb-2018 — /EuropaWire/ — Medtronic plc (NYSE:MDT), the global leader in…

6 years ago

University of Exeter’s Professor Andrew Hattersley earns CBE for his work in diabetes research

EXETER, 09-Feb-2018 — /EuropaWire/ — A world-leading diabetes expert today (Thursday 8th February) received his CBE for his work in revolutionising global…

6 years ago

University of Dundee: Smoking and diabetes are leading risk factors for peripheral artery disease (PAD)

research also points to diabetes as cause of disease that can lead to limb amputation DUNDEE, 20-Sep-2017 — /EuropaWire/ — Smoking…

7 years ago

Medtronic presented results of iPro2 Professional CGM at 9th International Conference on Advanced Technologies & Treatments for Diabetes

iPro2 Professional CGM Provides Information to Help Physicians Optimize Care for Their Patients Regardless of Their Diabetes Therapy MILAN, 08-Feb-2016…

8 years ago

University of Aberdeen: UK and US scientists made major step forward in understanding how the brain senses low glucose levels

For people suffering from diabetes, managing blood sugar can be like walking a tightrope - if too high they run…

9 years ago

University of Leicester led team published new findings about the link between low blood glucose and cardiovascular events

International team led by University of Leicester publish new findings Leicester, UK, 15-12-2014 — /EuropaWire/ — A study involving scientists…

9 years ago

Sanofi and Medtronic partner to improve patient experience and outcomes for people with diabetes around the world

Initial focus on insulin-device combinations and care management services Paris and Minneapolis, Minn., 16-6-2014 — /EuropaWire/ — Sanofi (EURONEXT: SAN and NYSE:…

10 years ago

HumEn project received €6M EU grant to develop stem cell-based treatment of diabetes

STEM CELLS A grant of 6 million euros for the HumEn project brings together leading European stem cell-research groups and industrial…

10 years ago

University of Leicester health research led by Professor Kamlesh Khunti received £28.4M funding to speed up impact for patients across East Midlands

12-8-2013 — /EuropaWire/ — Research led by University of Leicester health expert aims to speed up impact for patients across the…

11 years ago

Boehringer Ingelheim and Eli Lilly presented clinical trials results evaluating linagliptin efficacy and safety in Asians with Type 2 Diabetes

2-7-2013 — /europawire.eu/ — New Phase III data presented at the American Diabetes Association 73rd Scientific Sessions® (ADA) showed linagliptin improved…

11 years ago

Boehringer Ingelheim, Lilly released results of new meta-analysis regarding CV events in linagliptin Phase 3 trials presented at the American Diabetes Association

Ingelheim, Germany and Indianapolis, US, 1-7-2013 — /europawire.eu/ — Boehringer Ingelheim and Eli Lilly and Company today announced results from a…

11 years ago

EU Health Prize for Journalists seeks to reward excellence in health journalism, now open to 28 European countries

Brussels, 14-6-2013 — /europawire.eu/ — Today, the virtual doors swing open to journalists from across the EU wishing to participate in the…

11 years ago

Bayer HealthCare supports Middle East, North Africa and Europe diabetes projects under the “Excellence across Borders” program

Leverkusen, 12-6-2013 — /europawire.eu/ — Bayer HealthCare supports local projects under the “Excellence across Borders” program in order to improve care…

11 years ago